MetLife Investment Management’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.09M Sell
75,859
-2,075
-3% -$68.2K 0.01% 1131
2026
Q1
$2.9M Sell
77,934
-424
-0.5% -$17.5K 0.01% 869
2025
Q4
$3.67M Sell
78,358
-4,924
-6% -$213K 0.02% 774
2025
Q3
$3.49M Sell
83,282
-3,352
-4% -$147K 0.02% 808
2025
Q2
$3.81M Sell
86,634
-2,795
-3% -$127K 0.02% 688
2025
Q1
$4.51M Sell
89,429
-2,233
-2% -$111K 0.02% 664
2024
Q4
$3.94M Buy
91,662
+6,733
+8% +$284K 0.02% 696
2024
Q3
$3.33M Sell
84,929
-2,443
-3% -$88.3K 0.02% 761
2024
Q2
$2.81M Sell
87,372
-5,401
-6% -$174K 0.02% 815
2024
Q1
$3.06M Sell
92,773
-3,345
-3% -$116K 0.02% 769
2023
Q4
$3.34M Buy
+96,118
New +$3.32M 0.02% 711
2023
Q3
– Sell
-103,583
Closed -$3.89M – 2921
2023
Q2
$3.89M Sell
103,583
-3,580
-3% -$144K 0.03% 601
2023
Q1
$4.95M Sell
107,163
-3,026
-3% -$141K 0.04% 447
2022
Q4
$5.1M Sell
110,189
-2,414
-2% -$110K 0.04% 423
2022
Q3
$4.93M Sell
112,603
-2,286
-2% -$105K 0.04% 412
2022
Q2
$4.87M Buy
114,889
+3,955
+4% +$168K 0.04% 436
2022
Q1
$4.83M Buy
110,934
+27,090
+32% +$1.26M 0.03% 557
2021
Q4
$4.45M Buy
83,844
+869
+1% +$43.7K 0.04% 458
2021
Q3
$3.94M Sell
82,975
-4,070
-5% -$202K 0.04% 488
2021
Q2
$3.95M Buy
+87,045
New +$3.94M 0.03% 517
2019
Q2
– Sell
-213
Closed -$7.49K – 2494
2019
Q1
$7.49K Buy
213
+12
+6% +$379 ﹤0.01% 2531
2018
Q4
$5.42K Sell
201
-1
-0.5% -$28 ﹤0.01% 2454
2018
Q3
$6.18K Buy
+202
New +$6.13K ﹤0.01% 2504

Other funds holding G

MetLife Investment Management's G Position: Q2 2026 in Review

MetLife Investment Management reduced its Genpact (G) stake by 2.7% in Q2 2026, selling an estimated $68.2K and leaving 75,859 shares worth $2.09M. The position accounts for 0.01% of the portfolio, ranked #1131.

MetLife Investment Management first reported a position in G in Q3 2018 and has held it in 23 quarters since. The position peaked at $5.1M in Q4 2022. 480 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • MetLife Investment Management held 75,859 shares of Genpact worth $2.09M as of Q2 2026.
  • MetLife Investment Management sold 2,075 Genpact shares in Q2 2026, an estimated $68.2K.
  • Genpact made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1131 holding.
  • MetLife Investment Management first reported a position in Genpact in Q3 2018 and has held it in 23 quarters since.
  • MetLife Investment Management's Genpact position peaked at $5.1M in Q4 2022.
  • 480 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.